
PharmaTher Builds Network of 3D Printing Nodes for Rare Disease, Shortage and Emergency Medicines
Where is AI unlocking advantages? Explore what is possible at AMA: Software 2026. Canadian specialty pharmaceutical company PharmaTher Holdings has launched the M3DICINES National Network Program, an initiative to build a distributed network of qualified sites across North America that produce personalized medicines on CraftMake pharmaceutical 3D printers. The program will begin with U.S. 503A…
Article opens at the original publisher in a new tab. We link, we don’t mirror.





